Bellerophon Therapeutics

Bellerophon Therapeutics is a clinical-stage biotherapeutics company focused on developing innovative products combining novel drugs and devices in the treatment of cardiopulmonary and cardiac diseases. Our mission is to develop well-studied molecules deployed through innovative delivery systems to treat diseases with significant unmet clinical need.

Website

http://www.bellerophon.com

External link for Bellerophon Therapeutics

Industry

Biotechnology Research

Company size

11-50 employees

Headquarters

Warren, New Jersey

Type

Public Company

Founded

2014